首页> 外文期刊>Oncology letters >New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells
【24h】

New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells

机译:吖啶橙色荧光染色方法的新应用:循环肿瘤细胞的筛选

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study was to explore use of the acridine orange fluorescence (AO-F) staining method for screening of circulating tumor cells (CTCs) in renal cell carcinoma (RCC) patients. The AO-F positive staining rate of live and dead tumor cells was calculated. The positive staining rate in the live group was 93.4 +/- 3.0%, while the dead group failed to emit specific fluorescence. A known number of tumor cells were added to peripheral blood, and the detection sensitivity of the four groups (50, 100, 200 and 500 cells/tube) was 10.2 +/- 3.8, 9.2 +/- 2.3, 10.8 +/- 2.6 and 10.5 +/- 1.9%, respectively. The average detection sensitivity of the four groups was 10.16 +/- 2.73%. There was a positive correlation between the number of cells that was positively stained with AO-F and the total number cells in the system (chi(2)=0.959; P < 0.001). Subsequently, the AO-F staining method was used to detect positive staining cells in 8 healthy volunteers (control group), and 112 non-metastatic and 27 metastatic RCC patients. The positive staining rate was 13.67% (19/139) in RCC patients, while none of the control group was positive. The AO-F positive staining rate was not significantly different between the metastatic and non-metastatic patients according to age, gender, the pathological pattern, T2/3 (according to the Tumor-Node-Metastasis classification) or Fuhrman grade, while there was a significant difference according to T1. The positive staining rate was 8.93% (10/112) for non-metastatic patients and 33.33% (9/27) for metastatic patients, which showed a significant difference (P < 0.05). In 112 non-metastatic and 27 metastatic patients, the positive staining rate was not significantly associated with gender, age, tumor size, the pathological pattern, T classification, Fuhrman grade, the presence of a lesion or metastasis to the lungs. The present study demonstrated that the method of CTC staining with AO-F, which has high reproducibility and specificity, was feasible for identifying CTCs and warrants further study.
机译:本研究的目的是探讨吖啶橙色荧光(AO-F)染色方法,用于筛选肾细胞癌(RCC)患者的循环肿瘤细胞(CTC)。计算了活肿瘤细胞的AO-F阳性染色率。 Live组的阳性染色率为93.4 +/- 3.0%,而死亡组未能发出特定的荧光。将已知数量的肿瘤细胞加入外周血,并且四组(50,100,200和500个细胞/管)的检测灵敏度为10.2 +/- 3.8,9.2 +/- 2.3,10.8 +/- 2.6分别为10.5 +/- 1.9%。四组的平均检测灵敏度为10.16 +/- 2.73%。用AO-F呈正染色的细胞数与系统中的总数细胞之间存在正相关性(CHI(2)= 0.959; p <0.001)。随后,使用AO-F染色方法检测8个健康志愿者(对照组)和112个非转移和27例转移患者的阳性染色细胞。 RCC患者中阳性染色率为13.67%(19/139),而没有对照组呈阳性。根据年龄,性别,病理模式,T2 / 3(根据肿瘤节点转移分类)或FUHRMAN等级,转移和非转移性患者之间的AO-F阳性染色速率没有显着差异。根据T1的显着差异。对于非转移性患者,阳性染色率为8.93%(10/112),可用于转移患者33.33%(9/27),显示出显着差异(P <0.05)。在112例非转移和27例转移性患者中,阳性染色率与性别,年龄,肿瘤大小,病理模式,急诊症,福尔曼等级,病变或转移的存在效果显着相关。本研究证明,具有高再现性和特异性的AO-F的CTC染色方法对于鉴定CTC,并且需要进一步研究是可行的。

著录项

  • 来源
    《Oncology letters》 |2017年第1期|共9页
  • 作者单位

    Second Hosp Tianjin Med Univ Tianjin Inst Urol Tianjin 300211 Peoples R China;

    Second Hosp Tianjin Med Univ Tianjin Inst Urol Tianjin 300211 Peoples R China;

    Second Hosp Tianjin Med Univ Tianjin Inst Urol Dept Urol 23 Pingjiang Rd Tianjin 300211;

    Second Hosp Tianjin Med Univ Tianjin Inst Urol Dept Urol 23 Pingjiang Rd Tianjin 300211;

    Second Hosp Tianjin Med Univ Tianjin Inst Urol Dept Urol 23 Pingjiang Rd Tianjin 300211;

    Second Hosp Tianjin Med Univ Tianjin Inst Urol Dept Urol 23 Pingjiang Rd Tianjin 300211;

    Second Hosp Tianjin Med Univ Tianjin Inst Urol Dept Urol 23 Pingjiang Rd Tianjin 300211;

    Second Hosp Tianjin Med Univ Tianjin Inst Urol Dept Urol 23 Pingjiang Rd Tianjin 300211;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    circulating tumor cells; acridine orange fluorescence; renal cell carcinoma; cytodiagnosis;

    机译:循环肿瘤细胞;吖啶橙色荧光;肾细胞癌;细胞癌;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号